Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the program expands to Medicare Part B and smaller biotechs.
Immuno-Oncology Stars Keytruda, Opdivo Likely To Come Into IRA Crosshairs Read More »
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a new Fair Health report.
GLP-1 prescriptions for weight loss are shooting up, despite obstacles Read More »
Tom Cowhey served as finance chief at CVS before the healthcare giant named a new CFO in April.
¿Quién protege tu información personal cuando compras online o haces una transferencia desde el móvil? Detrás de esa seguridad hay profesionales que trabajan desde el otro lado del espejo digital. Se llaman “hackers éticos” o “hacker …
Hacking ético: cómo trabajan los hackers legales y qué debes estudiar para ser uno Read More »
In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical data to support the repeat COVID-19 booster strategy in children.
RFK Jr. Removes CDC COVID Vaccine Recommendation for Healthy Children, Pregnant Women Read More »
InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.
InflaRx Axes Rare Skin Disease Study on Disappointing Late-Stage Data Read More »
A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such disclosures.
Drug Price Transparency in US Is Easier Said Than Done Read More »
A spokesperson said the cuts came “after months of discernment, financial analysis and a thorough review of the dynamic healthcare market.” Open clinical roles will not be impacted.
PeaceHealth to cut 1% of workforce, freeze nonclinical hiring through 2025 Read More »
Rouzbeh Haghighat was serving on the board of Chinook Therapeutics at the time of the Novartis acquisition and, according to the DOJ’s allegations, used confidential information to conduct insider trading.
Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy Read More »
The layoffs will take effect on July 22 and particularly target those working in sales, data engineering and product management.
AbbVie’s Allergan Cuts Over 200 Staff After Botched Marketing Campaign Read More »
